MEOX2 mediates cisplatin resistance in ovarian cancer via E2F target and DNA repair pathways

Table 1 Correlation analysis between MEOX2 expression and clinical data in tissue chips

	variable	MEOX2 expression		total	P-value	r-value
	variable	low	high	total	P-value	r-value
Age (year)	≤ 51	36	32	68	0.863	0.029
Age (year)	> 51	33	33	66	0.863	0.029
Grade	I/II	22	12	34	0.014	0.242
Grade	III	29	46	75	0.014	0.242
Tumor size	≤ 12.2 cm	42	27	69	0.025	0.2
Tumor size	> 12.2 cm	27	39	66	0.025	0.2
T stage	T1/T2	25	16	41	0.138	0.132
T stage	T3	43	49	92	0.138	0.132
N stage	N0	56	43	99	0.046	0.186
N stage	N1	12	22	34	0.046	0.186
M stage	M0	60	45	105	0.01	0.233
M stage	M1	8	20	28	0.01	0.233
TNM stage	I/II	25	16	41	0.138	0.132
TNM stage	III/IV	43	49	92	0.138	0.132

ISSN: 1757-2215